HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.

Abstract
Primary cutaneous CD30-positive (anaplastic) large T-cell lymphomas and lymphomatoid papulosis are closely related types of cutaneous T-cell lymphoma with a favorable prognosis. The neoplastic T cells in these conditions have the phenotype of activated CD3+, CD4+, CD8-, CD30+ skin homing T cells, but their normal counterpart has not yet been defined. To further characterize the cellular origin of the neoplastic T cells, skin biopsies from 14 patients with primary cutaneous CD30-positive (anaplastic) large T-cell lymphomas, nine patients with lymphomatoid papulosis, and six patients with primary cutaneous CD30-negative pleomorphic large T-cell lymphomas were stained with monoclonal antibodies against cytotoxic cell-associated molecules granzyme B and T-cell restricted intracellular antigen. In nine of nine lymphomatoid papulosis and in 10 of 14 CD30-positive primary cutaneous large T-cell lymphomas, expression of granzyme B and T-cell restricted intracellular antigen by variable numbers of neoplastic cells was found. Expression of granzyme B by the neoplastic CD30-positive T cells was confirmed by double-staining for granzyme B and CD30 (three cases) and by the detection of granzyme B mRNA using RNA in situ hybridization (one case). In most cases equal numbers of granzyme-B-positive and T-cell restricted intracellular antigen positive tumor cells were observed. In five of six CD30-negative primary cutaneous large T-cell lymphomas the neoplastic cells did not express these proteins, whereas in one case a sporadic positive tumor cell was found. These results demonstrate that, in contrast to primary cutaneous CD30-negative pleomorphic large T-cell lymphomas, the neoplastic cells in most primary cutaneous CD30-positive (anaplastic) large T-cell lymphomas and lymphomatoid papulosis have a unique CD4+, CD8-, cytotoxic T-cell phenotype.
AuthorsJ A Kummer, M H Vermeer, D Dukers, C J Meijer, R Willemze
JournalThe Journal of investigative dermatology (J Invest Dermatol) Vol. 109 Issue 5 Pg. 636-40 (Nov 1997) ISSN: 0022-202X [Print] United States
PMID9347791 (Publication Type: Journal Article)
Chemical References
  • Ki-1 Antigen
  • Membrane Proteins
  • Poly(A)-Binding Proteins
  • Proteins
  • RNA-Binding Proteins
  • T-Cell Intracellular Antigen-1
  • TIA1 protein, human
  • Granulocyte Colony-Stimulating Factor
  • GZMB protein, human
  • Granzymes
  • Serine Endopeptidases
Topics
  • CD4-Positive T-Lymphocytes (metabolism)
  • Granulocyte Colony-Stimulating Factor (biosynthesis)
  • Granzymes
  • Humans
  • Ki-1 Antigen (analysis)
  • Lymphoma, Large B-Cell, Diffuse (genetics, immunology)
  • Lymphoma, T-Cell, Cutaneous (genetics, immunology)
  • Lymphoproliferative Disorders (genetics, immunology)
  • Membrane Proteins (biosynthesis)
  • Phenotype
  • Poly(A)-Binding Proteins
  • Proteins
  • RNA-Binding Proteins (biosynthesis)
  • Serine Endopeptidases (biosynthesis)
  • T-Cell Intracellular Antigen-1

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: